Literature DB >> 16392096

Hyperlactacidemia potentially due to linezolid overexposure in a liver transplant recipient.

Federico Pea, Luigia Scudeller, Manuela Lugano, Umberto Baccarani, Federica Pavan, Marcello Tavio, Mario Furlanut, Giorgio Della Rocca, Fabrizio Bresadola, Pierluigi Viale.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16392096     DOI: 10.1086/499533

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  19 in total

1.  Linezolid underexposure in a patient co-treated with venlafaxine.

Authors:  Piergiorgio Cojutti; Massimo Crapis; Matteo Bassetti; William Hope; Federico Pea
Journal:  Eur J Clin Pharmacol       Date:  2015-08-08       Impact factor: 2.953

2.  A case of lactic acidosis induced by linezolid.

Authors:  Juan Carlos Q Velez; Michael G Janech
Journal:  Nat Rev Nephrol       Date:  2010-04       Impact factor: 28.314

3.  Successful long-term treatment of cerebral nocardiosis with unexpectedly low doses of linezolid in an immunocompromised patient receiving complex polytherapy.

Authors:  Federico Pea; Piergiorgio Cojutti; Alberto Pagotto; Francesco Cristini; Mario Furlanut; Pierluigi Viale
Journal:  Antimicrob Agents Chemother       Date:  2012-02-27       Impact factor: 5.191

Review 4.  Pharmacological issues of linezolid: an updated critical review.

Authors:  Antonello Di Paolo; Paolo Malacarne; Emanuele Guidotti; Romano Danesi; Mario Del Tacca
Journal:  Clin Pharmacokinet       Date:  2010-07       Impact factor: 6.447

5.  A 1 year retrospective audit of quality indicators of clinical pharmacological advice for personalized linezolid dosing: one stone for two birds?

Authors:  Federico Pea; Piergiorgio Cojutti; Lucia Dose; Massimo Baraldo
Journal:  Br J Clin Pharmacol       Date:  2015-12-05       Impact factor: 4.335

Review 6.  Pharmacologically-induced metabolic acidosis: a review.

Authors:  George Liamis; Haralampos J Milionis; Moses Elisaf
Journal:  Drug Saf       Date:  2010-05-01       Impact factor: 5.606

7.  Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis.

Authors:  Federico Pea; Mario Furlanut; Piergiorgio Cojutti; Francesco Cristini; Eleonora Zamparini; Loretta Franceschi; Pierluigi Viale
Journal:  Antimicrob Agents Chemother       Date:  2010-08-23       Impact factor: 5.191

8.  Linezolid-induced lactic acidosis in two liver transplant patients with the mitochondrial DNA A2706G polymorphism.

Authors:  J L Del Pozo; N Fernández-Ros; E Sáez; J I Herrero; J R Yuste; J M Banales
Journal:  Antimicrob Agents Chemother       Date:  2014-05-05       Impact factor: 5.191

9.  Linezolid and lactic acidosis: a role for lactate monitoring with long-term linezolid use in children.

Authors:  Erik Su; Kelli Crowley; Joseph A Carcillo; Marian G Michaels
Journal:  Pediatr Infect Dis J       Date:  2011-09       Impact factor: 2.129

10.  Pharmacokinetics of tedizolid in subjects with renal or hepatic impairment.

Authors:  S Flanagan; S L Minassian; D Morris; R Ponnuraj; T C Marbury; H W Alcorn; E Fang; P Prokocimer
Journal:  Antimicrob Agents Chemother       Date:  2014-08-18       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.